Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
about
Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth.Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionSimultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsRole of leukotrienes in N-(3,5-dichlorophenyl)succinimide (NDPS) and NDPS metabolite nephrotoxicity in male Fischer 344 ratsThe role of peroxisome proliferator-activated receptors in colorectal cancer.Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation.Peroxisome proliferator-activated receptors and progression of colorectal cancer.Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cellsPPARs Mediate Lipid Signaling in Inflammation and Cancer.Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure.Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.The Role of PPARs in the Endothelium: Implications for Cancer TherapyMinireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop.MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma.Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation.Ionomycin induces prostaglandin E2 formation in murine osteoblastic MC3T3-E1 cells via mechanisms independent of its ionophoric nature.PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines.PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma.PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer.High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.The overexpression of AP-4 as a prognostic indicator for gastric carcinoma.C/VDdb: A multi-omics expression profiling database for a knowledge-driven approach in cardiovascular disease (CVD)
P2860
Q26824893-2F453DFA-25B6-4E29-844E-A214A018E41EQ27687166-1CD1820C-C220-4FF2-8632-C3B1B9E92243Q34086015-ECF2A37E-81C5-47C5-9D15-079C78CFB799Q34483561-4FC9F4AB-67AC-47A8-B3FC-98C3DE3F02B3Q35036189-5E8B563B-A431-4539-8FF4-D0D0FE974039Q35539784-4B4B1EDB-C2A0-4D38-B3B0-D167384BEDB4Q35673201-579FE8BE-E28B-45F2-B261-5025A789C4DCQ36142142-C9D54585-804D-48EF-821B-ED7D257BAF4BQ36248494-9F946CF1-2C48-4844-A7BC-B2B1C98773F7Q36318813-0042EE0E-8CDA-4C5B-A0D2-94590B9652A2Q36393316-8ED99F10-4418-44CE-B6DD-03B32C290A4AQ36458927-185C85BF-30FB-4D6B-90A6-50470F6FDFE8Q36675898-3EC9912B-D3D8-4F3E-B96A-94BC9C79536CQ36710291-FCEB7D75-8C83-4434-A4CC-23D162F7AB0FQ36954636-08C78283-933E-45EA-AF9F-BFB92DFA5ADCQ37021709-3CB0EDAB-8F4F-4A1D-915F-35AC4D6FF5D2Q37120406-79B31F3B-454C-453A-A2EC-226E350513F5Q37190455-207FB40E-B0EC-430C-AB24-8AAE2FF8BABFQ37231752-0188C011-F402-4B9B-A4DE-303FF9FAC7C1Q37337997-E9F76FA9-54CC-4B15-8099-043B8495D595Q37656896-A4589B3B-8988-43B9-AE8A-D44A4D1B0D40Q37708993-6C09ED9F-2547-4865-A17C-8674FD30211CQ38701714-ED92BE75-733B-48CE-8556-24B4C3AF218BQ38736745-CF318FBC-2FDE-48B7-92E7-8D6EC4C5A815Q38779290-F7F6B3DC-09C7-468B-86EA-F9A368186363Q39145017-DF2ED105-EAE2-423A-BEE7-539B0722F8D2Q41983546-E9E96DF2-C2ED-47D7-B0C7-3805A2DD8C4FQ42125206-7BAB03E1-A269-4338-B181-D4276DDA9DA3Q42250957-5E876915-5F3F-4FA4-8726-2F9CF892A3C6Q43191818-33358E3C-015A-4186-B23E-D83A8A04F2ACQ45916574-1A1C34BC-2907-4E84-968F-52C01A789CE7Q52962540-9DCEB2D4-B3CC-4367-921D-3C6932BADCCDQ54288204-354006BD-A747-4BB9-A695-717C55D3DEA4Q54386815-BCC9A578-1AEC-4C68-B5D8-E9583C3B4983Q59136824-93B0AE3A-B450-4B91-BFB7-658D6BECD583
P2860
Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Peroxisome-proliferator-activa ...... bition of activator protein-1.
@en
type
label
Peroxisome-proliferator-activa ...... bition of activator protein-1.
@en
prefLabel
Peroxisome-proliferator-activa ...... bition of activator protein-1.
@en
P2093
P2860
P356
P1433
P1476
Peroxisome-proliferator-activa ...... ibition of activator protein-1
@en
P2093
Carmen Punzón
Manuel Fresno
Raquel Grau
P2860
P356
10.1042/BJ20050964
P407
P577
2006-04-01T00:00:00Z